Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4+CD25+ T cells

被引:207
作者
Suri-Payer, E [1 ]
Cantor, H [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
关键词
autoimmune gastritis; regulatory T Cells; CD25; cytokine; colitis;
D O I
10.1006/jaut.2000.0473
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine autoimmune gastritis, induced by neonatal thymectomy or the injection of CD25-depleted lymphocytes into nu/nu recipients, is characterized by an inflammatory infiltrate into the gastric mucose, parietal cell destruction and circulating anti-parietal cell antibodies. Using RAG-2(-/-) mice as recipients, we determined that the induction of disease relies on CD4(+)CD25(-) effector cells and prevention relies on CD4(+)CD25(+) regulatory cells; neither requires participation of CD8 cells or B cells. The severity of gastritis was dependent on the cytokine repertoire of CD4(+)CD25(-) effector T cells. Recipients of IL-4(-/-) T cells developed more severe gastritis and recipients of INF-gamma (-/-) T cells developed milder disease than recipients of wildtype or IL-10(-/-) effector T cells. Gastritis did not develop in the absence of IL-12. Protection from gastritis does not require either IL-4 or IL-10 because CD4(+)CD25(+) cells from IL-4(-/-) or IL-10(-/-) mice completely abrogated the disease process. CD4(+)CD25(+) cells also protected RAG-2(-/-) recipients from colitis and inhibitory activity was partially dependent on IL-10 expression. These findings highlight the critical role of CD4(+)CD25(+) regulatory T cells in protection from several autoimmune syndromes and delineate the differential contribution of IL-10 to CD4(+)CD25(+) Treg activity in the settings of gastritis and colitis. (C) 2001 Academic Press.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 55 条
  • [1] Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment
    Annacker, O
    Burlen-Defranoux, O
    Pimenta-Araujo, R
    Cumano, A
    Bandeira, A
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (07) : 3573 - 3580
  • [2] Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
    Asano, M
    Toda, M
    Sakaguchi, N
    Sakaguchi, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 387 - 396
  • [3] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
    Asseman, C
    Mauze, S
    Leach, MW
    Coffman, RL
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 995 - 1003
  • [4] Interferon-gamma is required during the initiation of an organ-specific autoimmune disease
    Barrett, SP
    Gleeson, PA
    deSilva, H
    Toh, BH
    vanDriel, IR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) : 1652 - 1655
  • [5] Begolka WS, 1998, RES IMMUNOL, V149, P771
  • [6] Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
    Berg, DJ
    Davidson, N
    Kuhn, R
    Muller, W
    Menon, S
    Holland, G
    ThompsonSnipes, L
    Leach, MW
    Rennick, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) : 1010 - 1020
  • [7] Bregenholt S, 1999, CLIN EXP IMMUNOL, V118, P228
  • [8] Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO
  • [9] 2-X
  • [10] IMMUNOGLOBULIN GENE REARRANGEMENT IN B-CELL DEFICIENT MICE GENERATED BY TARGETED DELETION OF THE J(H) LOCUS
    CHEN, JZ
    TROUNSTINE, M
    ALT, FW
    YOUNG, F
    KURAHARA, C
    LORING, JF
    HUSZAR, D
    [J]. INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) : 647 - 656